Search Results - pharmaceuticals+%26+therapeutics+%3e+pharma%3a+neurology

4 Results Sort By:
Glutamate Modulators to Treat Neurological and Psychiatric Disorders
PAGE TITLE Overview PAGE SUMMARY Prof. Sandhya Kortagere of Drexel University has developed glutamate transport modulators for treating neurological disorders caused by glutamate dysregulation. These drugs increase clearance of the neurotransmitter glutamate by cells containing GLT-1, an important modulator of the glutamatergic system. Administration...
Published: 8/27/2024   |   Inventor(s): Sandhya Kortagere
Keywords(s):  
Category(s): Pharmaceuticals & Therapeutics, Pharmaceuticals & Therapeutics > Pharma: Neurology, Pharmaceuticals & Therapeutics > Pharma: Neurodegeneration
NOVEL GLUTAMATE TRANSPORTER ACTIVATORS AND METHODS USING SAME
PAGE TITLENeuroprotective agent for Parkinson’s DiseasePAGE SUMMARYParkinson’s Disease (PD) is a progressive neurological disorder whose prevalence increases with age and certain genetic predispositions. It is estimated that 7-10 million people are affected by Parkinson’s Disease worldwide, with 1 million in the United States. Currently,...
Published: 8/27/2024   |   Inventor(s): Sandhya Kortagere, Ole Mortensen, Andreia Mortensen, Joseph Salvino
Keywords(s):  
Category(s): Pharmaceuticals & Therapeutics, Pharmaceuticals & Therapeutics > Pharma: Neurodegeneration, Pharmaceuticals & Therapeutics > Pharma: Neurology
Novel compositions useful in treating brain-related diseases or disorders and methods using same
PAGE TITLEOverviewPAGE SUMMARY The present invention provides compounds useful for treating or preventing a brain-related disease or disorder. The present invention further provides a method of treating or preventing a brain-related disease or disorder in a patient, the method comprising administering to the patient a pharmaceutical composition comprising...
Published: 8/27/2024   |   Inventor(s): Sandhya Kortagere, Ole Mortensen, Andreia Mortensen, Joseph Salvino
Keywords(s):  
Category(s): Pharmaceuticals & Therapeutics, Pharmaceuticals & Therapeutics > Pharma: Neurodegeneration, Pharmaceuticals & Therapeutics > Pharma: Neurology
CHEC Peptides to Treat Epilepsy and Seizure
PAGE TITLE CHEC peptides as therapies for neurological disorders and a noninvasive diagnostic assay for monitoring inflammatory damage PAGE SUMMARY Diagnostic Monitor: The Cunningham lab has discovered methods to monitor central and peripheral nervous system neuronal damage resulting from an increase in the inflammatory enzyme secreted phospholipase...
Published: 7/22/2024   |   Inventor(s): Timothy Cunningham, Barry Waterhouse, Melanie Alexander
Keywords(s):  
Category(s): Pharmaceuticals & Therapeutics, Pharmaceuticals & Therapeutics > Pharma: Neurology